Abbvie Inc. vs United Therapeutics Corp
ABBV vs UTHR — side-by-side comparison from reported financials. ABBV leads 3, UTHR leads 8 of 11 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
United Therapeutics Corp
UTHR · Healthcare
$549.16+3.07%Strong
| Metric | ABBV | UTHR |
|---|---|---|
| Price | $276.43 | $549.16 |
| Market cap | $488B | $23.6B |
| Revenue (TTM) | $64.4B | $3.15B |
| Revenue growth | +1.8% | +18.0% |
| Net margin | 9.8% | 41.6% |
| Free cash flow | $18.2B | $1.09B |
| Net cash (debt) | ($56.2B) | $2.88B |
| 1-year price return | +19.8% | +23.3% |
| P/E | 77.4 | 18.0 |
| P/E vs own history (cheap-side %) | 23% | 26% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | 20% |
| Altman Z-score | 2.33 | 21.46 |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 1,400 |
Full résumé-style profiles: ABBV CV · UTHR CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.